TrialViruses2025

Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study.

Diana Hernández-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.